No Picture
News

BioMarin’s Biologics License Application for Valoctocogene Roxaparvovec Accepted for Priority Review by FDA with Review Action Date of August 21, 2020

No Advisory Committee Meeting Currently Planned to Review the ApplicationIf approved, 1st Gene Therapy in U.S. for the Treatment of Any Type of HemophiliaFDA Also Accepts Premarket Approval (PMA) Application for Companion Diagnostic Test, a 1st for a G… […]

No Picture
News

VistaGen Therapeutics Reports Fiscal 2020 Third Quarter Financial Results and Provides CNS Pipeline Overview

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2020 /PRNewswire/ — VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet … […]

No Picture
News

Trovagene Presents Phase 2 Data Demonstrating the Ability of Onvansertib to Overcome Zytiga®-Resistance and Provide Clinical Benefit for mCRPC Patients

– Onvansertib demonstrates efficacy in Zytiga®-resistant metastatic castration-resistant prostate cancer (mCRPC) across known androgen receptor resistance mechanisms- Onvansertib-induced decreases in circulating tumor cells (CTCs) is a surrogate for ef… […]

No Picture
News

Thermo Fisher Scientific Announces Collaboration to Develop Highly Sensitive Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring

SAN JOSE, Calif., Feb. 13, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and quantified results from patient blood… […]

No Picture
News

Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 /PRNewswire/ — Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results for the fourth quarter and full year … […]

No Picture
News

Valgenesis To Digitize Validation Processes Across Multiple Sites For A Global Contract Development And Manufacturing Organization (CDMO) Based In Southern Europe

SAN FRANCISCO, Feb. 11, 2020 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that one of the largest CDMOs in southern Europe has chosen ValGenesis’s 100% paperless VL… […]

No Picture
News

Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn’s and Colitis Organization (ECCO)

NEWARK, Calif., Feb. 7, 2020 /PRNewswire/ — Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that the Company will present preclinical data on PN-943, the Company’s oral, gut-restricted, alpha-4-beta-7 inhibitor candidate therapeutic, a… […]

No Picture
News

BioMarin Announces CFO Succession

Brian R. Mueller, Chief Accounting Officer and 17-year company veteran, named acting CFODan Spiegelman steps down as CFO; will assist with transition until September 1, 2020

SAN RAFAEL, Calif., Feb. 3, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc… […]